Transce3nd’s MIRA Pharmaceuticals MIRA Stock Holding History

Transce3nd’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,500	Closed	-$19.9K	–	1428
2024 Q4	$19.9K	Buy	+17,500	New	+$22.9K	0.01%	565

Other funds holding MIRA

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SEM

Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

PWM

Praetorian Wealth Management Carmel, California $580M AUM 19.43% 1-Year Est. Return

Transce3nd's MIRA Position: Q1 2025 in Review

Transce3nd sold out of MIRA Pharmaceuticals (MIRA) in Q1 2025, closing a stake of 17,500 shares — an estimated $19.9K sold.

Transce3nd first reported a position in MIRA in Q4 2024 and held it in 1 quarter. The position peaked at $19.9K in Q4 2024. 19 funds tracked by Wall St. Rank hold MIRA as of Q1 2025.

Transce3nd reported no remaining MIRA Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Transce3nd sold 17,500 MIRA Pharmaceuticals shares in Q1 2025, an estimated $19.9K.
Transce3nd first reported a position in MIRA Pharmaceuticals in Q4 2024 and held it in 1 quarter.
Transce3nd's MIRA Pharmaceuticals position peaked at $19.9K in Q4 2024.
19 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.